Alamar生物科学公司推出了NULISASeqTM Neuro 220小组,这是用于神经疾病研究的一个新的精确蛋白质组学工具。 Alamar Biosciences launched the NULISAseq™ Neuro 220 Panel, a new precision proteomics tool for neurological disease research.

Alamar生物科学公司推出了NULISASeqTM Neuro 220小组,这是其设计用于神经疾病研究的最广泛的精确蛋白质组平台。 Alamar Biosciences has launched the NULISAseq™ Neuro 220 Panel, its most extensive precision proteomics platform designed for neurological disease research. 该面板具有高度的敏感性和特殊性,有助于详细分析与脑紊乱相关的蛋白质。 The panel offers high sensitivity and specificity, enabling detailed analysis of proteins linked to brain disorders. 它旨在支持早期发现、生物标志发现和增进对阿尔茨海默氏病和帕金森病等病情的理解。 It aims to support early detection, biomarker discovery, and improved understanding of conditions like Alzheimer’s and Parkinson’s disease. 该发射标志着神经科学蛋白质组学工具的重大进步。 The launch marks a significant advancement in proteomic tools for neuroscience.